EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign

Ester Colarusso iD, Erica Gazzillo, Eleonora Boccia, Stefania Terracciano, Ines Bruno, Giuseppe Bifulco, Maria Giovanna Chini, Gianluigi Lauro iD

Molecules · 2024

DOI: 10.3390/molecules29174025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Ester Colarusso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy. Hauptthemen laut MEDLINE: Transcription Factors, Cell Cycle Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, AIRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 3D structure-based pharmacophore model built for bromodomain-containing protein 4 (BRD4) is reported here, specifically developed for investigating and identifying the key structural features of the (+)-JQ1 known inhibitor within the BRD4 binding site. Using this pharmacophore model, 273 synthesized and purchased compounds previously considered for other targets but yielding poor results were screened in a drug repositioning campaign. Subsequently, only six compounds showed potential as BRD4 binders and were subjected to further biophysical and biochemical assays. Compounds 2, 5, and 6 showed high affinity for BRD4, with IC50 values of 0.60 ± 0.25 µM, 3.46 ± 1.22 µM, and 4.66 ± 0.52 µM, respectively. Additionally, these compounds were tested against two other bromodomains, BRD3 and BRD9, and two of them showed high selectivity for BRD4. The reported 3D structure-based pharmacophore model proves to be a straightforward and useful tool for selecting novel BRD4 ligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsCell Cycle ProteinsHumansProtein BindingLigandsDrug RepositioningBinding SitesNuclear ProteinsTriazolesAzepinesMolecular Docking SimulationModels, MolecularStructure-Activity RelationshipDrug Evaluation, PreclinicalPharmacophoreBromodomain Containing Proteins

Stichwörter der Autor:innen

anticancer agentsbromodomainchemical synthesiscomputational techniquesdrug discoverydrug repositioning

Substanzen

Transcription FactorsCell Cycle ProteinsBRD4 protein, humanLigandsNuclear ProteinsTriazolesAzepines(+)-JQ1 compoundBRD3 protein, humanBRD9 protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy.
  • Department of Biosciences and Territory, University of Molise, Contrada Fonte Lappone, 86090 Pesche, Italy.

ORCID-Profile: Ester Colarusso, Gianluigi Lauro

Förderung

  • Italian Association for Cancer Research
  • AIRC

Zitieren

APA

Colarusso, E., Gazzillo, E., Boccia, E., Terracciano, S., Bruno, I., Bifulco, G., Chini, M. G., & Lauro, G. (2024). Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign. Molecules. https://doi.org/10.3390/molecules29174025

Vancouver

Colarusso E, Gazzillo E, Boccia E, Terracciano S, Bruno I, Bifulco G, et al. Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign. Molecules. 2024. doi:10.3390/molecules29174025

BibTeX
@article{Colarusso2024,
  author = {Colarusso, Ester and Gazzillo, Erica and Boccia, Eleonora and Terracciano, Stefania and Bruno, Ines and Bifulco, Giuseppe and Chini, Maria Giovanna and Lauro, Gianluigi},
  title = {Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29174025}
}
Kostenlos starten →